Table 3 Within group and between group change between pre vs. Active and pre vs. post intervention period for the both intervention and control
Within Group Change | Between Group Change | |||||||
|---|---|---|---|---|---|---|---|---|
Intervention | Control | Intervention vs. Control | ||||||
Number, n (%) | OR (95% CI) | p-value | Number, n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Excellent Outcome (Three month post treatment mRS 0–2) | ||||||||
Pre-intervention period | 107 (47%) | Reference | Reference | 66 (32%) | Reference | Reference | Reference | Reference |
Active intervention period | 106 (45%) | 0.97 (0.62–1.51) | 0.878 | 74 (39%) | 1.15 (0.60–1.51) | 0.834 | 0.98 (0.54–1.92) | 0.966 |
Post intervention period | 72 (44%) | 0.96 (0.56–1.65) | 0.892 | 57 (36%) | 1.07 (0.59–1.59) | 0.906 | 0.99 (0.48–2.05) | 0.983 |
Poor Outcome (Three month post treatment mRS 5–6) | ||||||||
Pre-intervention period | 37 (16%) | Reference | Reference | 44 (21%) | Reference | Reference | Reference | Reference |
Active intervention period | 34 (14%) | 0.84 (0.47–1.51) | 0.568 | 29 (15%) | 0.78 (0.43–1.40) | 0.397 | 1.09 (0.48–2.49) | 0.843 |
Post intervention period | 24 (15%) | 0.43 (0.19–0.95) | 0.047 | 22 (14%) | 0.58 (0.31–1.08) | 0.087 | 0.74 (0.27–2.03) | 0.559 |
PH (Post treatment) | ||||||||
Pre-intervention period | 21 (7.4%) | Reference | Reference | 22 (7%) | Reference | Reference | Reference | Reference |
Active intervention period | 9 (3.2%) | 0.51 (0.22–1.18) | 0.115 | 16 (6.2%) | 0.95 (0.47–1.90) | 0.880 | 0.54 (0.18–1.60) | 0.265 |
Post intervention period | 10 (4.5%) | 0.82 (0.35–1.95) | 0.880 | 12 (6%) | 0.90 (0.42–1.91) | 0.780 | 0.92 (0.29–2.87) | 0.884 |